{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:38:06Z","timestamp":1782851886599,"version":"3.54.5"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFA1210203"],"award-info":[{"award-number":["2024YFA1210203"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273864"],"award-info":[{"award-number":["82273864"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People&apos;s Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["2025ZZ1020"],"award-info":[{"award-number":["2025ZZ1020"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["21ZR1407100"],"award-info":[{"award-number":["21ZR1407100"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["21S11905300"],"award-info":[{"award-number":["21S11905300"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.apsb.2025.12.026","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T16:23:28Z","timestamp":1766420608000},"page":"1140-1154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Skin-penetrating peptides derived from computational simulation improve transdermal absorption and facilitate topical treatment of melanoma"],"prefix":"10.1016","volume":"16","author":[{"given":"Sanjiang","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanlin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyang","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongxu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8003-2675","authenticated-orcid":false,"given":"Weiyue","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9600-0982","authenticated-orcid":false,"given":"Gang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2025.12.026_bib1","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/nbt.1504","article-title":"Transdermal drug delivery","volume":"26","author":"Prausnitz","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.apsb.2025.12.026_bib2","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.3109\/10717544.2016.1155243","article-title":"Development of transferosomal gel for trans-dermal delivery of insulin using iodine complex","volume":"23","author":"Marwah","year":"2016","journal-title":"Drug Deliv"},{"key":"10.1016\/j.apsb.2025.12.026_bib3","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3390\/s19051028","article-title":"Current advancements in transdermal biosensing and targeted drug delivery","volume":"19","author":"Pandey","year":"2019","journal-title":"Sensors"},{"key":"10.1016\/j.apsb.2025.12.026_bib4","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1073\/pnas.0501176102","article-title":"Design principles of chemical penetration enhancers for transdermal drug delivery","volume":"102","author":"Karande","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2025.12.026_bib5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/10717544.2013.801533","article-title":"Biomaterials as novel penetration enhancers for transdermal and dermal drug delivery systems","volume":"20","author":"Chen","year":"2013","journal-title":"Drug Deliv"},{"key":"10.1016\/j.apsb.2025.12.026_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.100898","article-title":"Overcoming negatively charged tissue barriers: drug delivery using cationic peptides and proteins","volume":"34","author":"Vedadghavami","year":"2020","journal-title":"Nano Today"},{"key":"10.1016\/j.apsb.2025.12.026_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2023.101252","article-title":"The skin barrier: an extraordinary interface with an exceptional lipid organization","volume":"92","author":"Bouwstra","year":"2023","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.apsb.2025.12.026_bib8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jconrel.2012.09.017","article-title":"Approaches for breaking the barriers of drug permeation through transdermal drug delivery","volume":"164","author":"Alexander","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.12.026_bib9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jconrel.2014.04.045","article-title":"Electrical, magnetic, photomechanical and cavitational waves to overcome skin barrier for transdermal drug delivery","volume":"193","author":"Wong","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.12.026_bib10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s12272-010-0301-7","article-title":"Recent advances in transdermal drug delivery","volume":"33","author":"Subedi","year":"2010","journal-title":"Arch Pharm Res (Seoul)"},{"key":"10.1016\/j.apsb.2025.12.026_bib11","doi-asserted-by":"crossref","first-page":"6517","DOI":"10.1039\/D0TB00713G","article-title":"Functional peptide-based drug delivery systems","volume":"8","author":"Lian","year":"2020","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.apsb.2025.12.026_bib12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2014.12.006","article-title":"Peptides as skin penetration enhancers: mechanisms of action","volume":"199","author":"Kumar","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.12.026_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201606596","article-title":"Getting drugs across biological barriers","volume":"29","author":"Yang","year":"2017","journal-title":"Adv Mater"},{"key":"10.1016\/j.apsb.2025.12.026_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.822","article-title":"The role of cell-penetrating peptides in potential anti-cancer therapy","volume":"12","author":"Zhou","year":"2022","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.apsb.2025.12.026_bib15","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/cbdd.12008","article-title":"Cell-penetrating peptides as a novel transdermal drug delivery system","volume":"80","author":"Nasrollahi","year":"2012","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.apsb.2025.12.026_bib16","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jconrel.2007.05.031","article-title":"Transdermal delivery enhanced by magainin pore-forming peptide","volume":"122","author":"Kim","year":"2007","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.12.026_bib17","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1016\/j.apsb.2021.07.014","article-title":"Membrane-disruptive peptides\/peptidomimetics-based therapeutics: promising systems to combat bacteria and cancer in the drug-resistant era","volume":"11","author":"Lin","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2025.12.026_bib18","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nbt1193","article-title":"Transdermal protein delivery by a coadministered peptide identified via phage display","volume":"24","author":"Chen","year":"2006","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.apsb.2025.12.026_bib19","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1021\/mp200594z","article-title":"Identification of a novel skin penetration enhancement peptide by phage display peptide library screening","volume":"9","author":"Kumar","year":"2012","journal-title":"Mol Pharm"},{"key":"10.1016\/j.apsb.2025.12.026_bib20","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/adhm.201500634","article-title":"De novo design of skin-penetrating peptides for enhanced transdermal delivery of peptide drugs","volume":"5","author":"Menegatti","year":"2016","journal-title":"Adv Healthcare Mater"},{"key":"10.1016\/j.apsb.2025.12.026_bib21","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1166\/jbn.2019.2658","article-title":"Percutaneous delivery application of acylated steric acid-9-p(arginine) cell penetrating peptides used as transdermal penetration enhancer+","volume":"15","author":"Wang","year":"2019","journal-title":"J Biomed Nanotechnol"},{"key":"10.1016\/j.apsb.2025.12.026_bib22","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jconrel.2012.01.025","article-title":"Penetratin-induced transdermal delivery from H(II) mesophases of sodium diclofenac","volume":"159","author":"Cohen-Avrahami","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.12.026_bib23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1021\/acs.biomac.5b01524","article-title":"Skin penetrating peptide as a tool to enhance the permeation of heparin through human epidermis","volume":"17","author":"Gennari","year":"2016","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.apsb.2025.12.026_bib24","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1016\/j.biomaterials.2012.04.056","article-title":"Combining poly-arginine with the hydrophobic counter-anion 4-(1-pyrenyl)-butyric acid for protein transduction in transdermal delivery","volume":"33","author":"Candan","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.apsb.2025.12.026_bib25","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/jid.2011.49","article-title":"Transduced PEP-1-FK506BP ameliorates atopic dermatitis in NC\/Nga mice","volume":"131","author":"Kim","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.apsb.2025.12.026_bib26","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3109\/03639045.2012.684388","article-title":"Transdermal absorption and stability enhancement of salmon calcitonin by Tat peptide","volume":"39","author":"Manosroi","year":"2013","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.apsb.2025.12.026_bib27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijpharm.2008.05.042","article-title":"Biochemical enhancement of transdermal delivery with magainin peptide: modification of electrostatic interactions by changing pH","volume":"362","author":"Kim","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2025.12.026_bib28","first-page":"2009","article-title":"Transportan in nanocarriers improves skin localization and antitumor activity of paclitaxel","volume":"11","author":"Pepe","year":"2016","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.apsb.2025.12.026_bib29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jconrel.2015.12.017","article-title":"Non-invasive topical delivery of plasmid DNA to the skin using a peptide carrier","volume":"222","author":"Vij","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.12.026_bib30","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/81359","article-title":"Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation","volume":"6","author":"Rothbard","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2025.12.026_bib31","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/s11095-005-2591-x","article-title":"Comparative study of the skin penetration of protein transduction domains and a conjugated peptide","volume":"22","author":"Lopes","year":"2005","journal-title":"Pharm Res"},{"key":"10.1016\/j.apsb.2025.12.026_bib32","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.pain.2010.02.024","article-title":"Peptide-mediated transdermal delivery of botulinum neurotoxin type A reduces neurogenic inflammation in the skin","volume":"149","author":"Carmichael","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.apsb.2025.12.026_bib33","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1600-0625.2007.00622.x","article-title":"Transdermal delivery of proteins mediated by non-covalently associated arginine-rich intracellular delivery peptides","volume":"16","author":"Hou","year":"2007","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.apsb.2025.12.026_bib34","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2025.12.026_bib35","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.abj8754","article-title":"Accurate prediction of protein structures and interactions using a three-track neural network","volume":"373","author":"Baek","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.apsb.2025.12.026_bib36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2147\/ITT.S134842","article-title":"Melanoma treatment in review","volume":"7","author":"Domingues","year":"2018","journal-title":"ImmunoTargets Ther"},{"key":"10.1016\/j.apsb.2025.12.026_bib37","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1126\/sciadv.aba2735","article-title":"Engineering bacterial outer membrane vesicles as transdermal nanoplatforms for photo-TRAIL-programmed therapy against melanoma","volume":"6","author":"Peng","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.apsb.2025.12.026_bib38","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1200\/JCO.1988.6.10.1653","article-title":"Fluorouracil: biochemistry and pharmacology","volume":"6","author":"Pinedo","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.apsb.2025.12.026_bib39","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2025.12.026_bib40","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jaad.2017.10.006","article-title":"Guidelines of care for the management of basal cell carcinoma","volume":"78","author":"Kim","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.apsb.2025.12.026_bib41","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jamadermatol.2017.3631","article-title":"Chemoprevention of basal and squamous cell carcinoma with a single course of fluorouracil, 5%, cream: a randomized clinical trial","volume":"154","author":"Weinstock","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.apsb.2025.12.026_bib42","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12943-023-01854-3","article-title":"Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches","volume":"22","author":"Hasan","year":"2023","journal-title":"Mol Cancer"},{"key":"10.1016\/j.apsb.2025.12.026_bib43","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1172\/JCI89820","article-title":"Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy","volume":"127","author":"Cunningham","year":"2017","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2025.12.026_bib44","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41592-022-01488-1","article-title":"ColabFold: making protein folding accessible to all","volume":"19","author":"Mirdita","year":"2022","journal-title":"Nat Methods"},{"key":"10.1016\/j.apsb.2025.12.026_bib45","doi-asserted-by":"crossref","first-page":"8385","DOI":"10.1002\/anie.202012643","article-title":"Connecting hydrophobic surfaces in cyclic peptides increases membrane permeability","volume":"60","author":"Hoang","year":"2021","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.apsb.2025.12.026_bib46","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jconrel.2018.06.023","article-title":"Cell penetrating peptides in ocular drug delivery: state of the art","volume":"284","author":"Pescina","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2025.12.026_bib47","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1039\/C6BM00884D","article-title":"A rapid albumin-binding 5-fluorouracil prodrug with a prolonged circulation time and enhanced antitumor activity","volume":"5","author":"Zhao","year":"2017","journal-title":"Biomater Sci"},{"key":"10.1016\/j.apsb.2025.12.026_bib48","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/17425247.2020.1713087","article-title":"Permeation enhancers in transdermal drug delivery: benefits and limitations","volume":"17","author":"Kov\u00e1\u010dik","year":"2020","journal-title":"Expet Opin Drug Deliv"},{"key":"10.1016\/j.apsb.2025.12.026_bib49","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1517\/13543770902989983","article-title":"Chemical penetration enhancers: a patent review","volume":"19","author":"Ahad","year":"2009","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.apsb.2025.12.026_bib50","doi-asserted-by":"crossref","first-page":"15816","DOI":"10.1073\/pnas.1016152108","article-title":"Delivery of siRNA and other macromolecules into skin and cells using a peptide enhancer","volume":"108","author":"Hsu","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2025.12.026_bib51","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1021\/mp300667p","article-title":"Effect of cationic cyclopeptides on transdermal and transmembrane delivery of insulin","volume":"10","author":"Chang","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1016\/j.apsb.2025.12.026_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/acsabm.3c00659","article-title":"Transdermal properties of cell-penetrating peptides: applications and skin penetration mechanisms","volume":"7","author":"Shin","year":"2024","journal-title":"ACS Appl Bio Mater"},{"key":"10.1016\/j.apsb.2025.12.026_bib53","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.addr.2004.10.010","article-title":"Cell-penetrating peptides: mechanism and kinetics of cargo delivery","volume":"57","author":"Zorko","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2025.12.026_bib54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/jdv.19559","article-title":"Actinic keratosis: current challenges and unanswered questions","volume":"38","author":"Malvehy","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.apsb.2025.12.026_bib55","article-title":"Bowen\u2019s disease","volume":"368","author":"Mohandas","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.apsb.2025.12.026_bib56","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.3390\/ijms25094674","article-title":"Pharmacotherapy for keloids and hypertrophic scars","volume":"25","author":"Murakami","year":"2024","journal-title":"Int J Mol Sci"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525008342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383525008342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T11:58:33Z","timestamp":1778846313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383525008342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2211383525008342"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2025.12.026","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skin-penetrating peptides derived from computational simulation improve transdermal absorption and facilitate topical treatment of melanoma","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2025.12.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}